Synergy Healthcare

#Eko wins #FDA clearance for #heart #murmur, #Afib algorithm - MedCity News http://ow.ly/eXTo30qeRSN  #healthtech #medicaldevice

Bill Gates pitches in on coronavirus R&D and containment efforts with $100M commitment – Endpoints Newshttp://ow.ly/Zsxk30qfheQ 

#ClinicalTrial is halted as #HIV #vaccine fails test in South Africa - STAThttp://ow.ly/bxHV30qeIq4 

The Wrong Way to Fight the #OpioidCrisis | The New Yorkerhttp://ow.ly/el5n30qfbmz 

Brain ‘hot spot’ may explain why African Americans feel greater pain - STAThttp://ow.ly/wEZ930qeIod 

Failed pivotal study? You can still have breakthrough therapy status — FDA signals to Resverlogix – Endpoints Newshttp://ow.ly/TXVW30qeEyN 

How important is #clinicalresearch? Containing the latest #pandemic is dependent upon the #clinicaltrial process to create an effective #vaccine. Can #Coronavirus Be Treated? #Gilead #Drug to Undergo Human #ClinicalTrials - Bloomberghttp://ow.ly/nh4U30qeRDP 

#FDA clears Sony’s #surgery video-sharing platform | FierceBiotech http://ow.ly/zMl530qeErN  #medicaldevice #development #healthtech

#Abbott to test its #heartdevice against lifetime #blood #thinners for reducing #stroke risk | FierceBiotech http://ow.ly/tsMY30qeEqg  #cardiovascular #medicaldevice #development

Chan Zuckerberg Initiative aims to build a model for tackling rare diseaseshttp://ow.ly/Jmui30qeIoR 

Gilead Sciences Offers Experimental Drug for Coronavirus Treatments, Testing - WSJ http://ow.ly/VRTl30qeBh5  #coronavirus

#Lilly’s #migraine reliever #Reyvow cleared for launch, setting up market battle with #Allergan’s #Ubrelvy | FiercePharmahttp://ow.ly/kBqY30qdZnm 

#GeNeuro raises €17.5M for #multiplesclerosis #clinicaltrial | FierceBiotech http://ow.ly/v59630qdXXK  #CNS #drugdevelopment

The 10 most-anticipated drug launches of 2020 | FiercePharmahttp://ow.ly/9nOp30qeBqU 

#Vertex drops VX-961 to continue search for perfect #pain drug | FierceBiotechhttp://ow.ly/GbI830qdXOW 

MIT researchers develop beating ‘biorobotic hybrid’ for testing heart valves | FierceBiotechhttp://ow.ly/9aXw30qdCuz 

A $442M failure: After years of work and an FDA rejection, Novartis calls it quits on Advair copy | FiercePharmahttp://ow.ly/TxvN30qdlRh 

#Akcea, #Pfizer hit #midphase goal, but data raise doubts about chances in #NAFLD, #diabetes | FierceBiotech http://ow.ly/N3oh30qdl9f  #cardiovascular #metabolic #disease #drugdevelopment #phaseII #clinicaltrial

#EliLilly notches another positive <baricitinib #eczema trial, but has <Dermira made it obsolete? – Endpoints News http://ow.ly/PVBw30qdCvw  #dermatology #drugdevelopment